Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure

Area of Science:

• Stem cell biology
• Reproductive medicine
• Regenerative medicine

Background:

• Premature ovarian failure (POF) causes infertility in women under 40.
• Tissue-specific stem cells show potential in restoring ovarian function.
• Human embryonic stem cells (ES-MSCs) offer a promising alternative for regenerative medicine due to their properties.

Purpose of the Study:

• To compare the efficacy of ES-MSCs and bone marrow-derived mesenchymal stem cells (BM-MSCs) in restoring ovarian function in a mouse model of chemotherapy-induced POF.
• To investigate the underlying mechanisms of ES-MSC therapeutic effects.

Main Methods:

• Chemotherapy (cyclophosphamide and busulfan) induced POF in female mice.
• Human ES-MSCs and BM-MSCs were transplanted into POF mice.
• Ovarian function was assessed by hormone levels, estrous cyclicity, and follicle counts.
• Apoptosis, gene expression, protein levels, and reproductive capacity were evaluated.

Main Results:

• Both ES-MSCs and BM-MSCs significantly restored ovarian hormone secretion, survival rates, and reproductive function in POF mice.
• Stem cell transplantation reduced follicular apoptosis and increased anti-apoptotic and trophic factors.
• Transplanted mice successfully produced offspring.

Conclusions:

• Human ES-MSCs are as effective as BM-MSCs in restoring ovarian structure and function in chemotherapy-induced POF.
• ES-MSC transplantation rescues fertility in POF mice, likely through paracrine mechanisms promoting follicular development and cell survival.